Monitoring tumour burden and therapeutic response through analysis of circulating tumour DNA and extracellular RNA in multiple myeloma patients

Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells

Jan Krönke, Namrata D. Udeshi, Anupama Narla et al. · Science · 2013 · 1.8K citations · Full text

Medicine, Cell Biology, Oncology +14

Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide

Antonia Lopez‐Girona, Derek Mendy, Takumi Ito et al. · Leukemia · 2012 · 798 citations · Full text

Medicine, Oncology, Pharmacology +15

Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma

Brian A. Walker, Eileen M. Boyle, Christopher P. Wardell et al. · Journal of Clinical Oncology · 2015 · 564 citations · Full text

Medicine, Molecular Genetics, Oncology +17

High-Dimensional Variable Selection for Survival Data

Hemant Ishwaran, Udaya B. Kogalur, Eiran Z. Gorodeski et al. · Journal of the American Statistical Association · 2010 · 454 citations

Computing, Bioinformatics, Biostatistics +15

Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing

Leo Rasche, Shweta S. Chavan, Owen Stephens et al. · Nature Communications · 2017 · 419 citations · Full text

Medicine, Hematology, Oncology +16